Events | Trainings

Child & Adolescent Mental
Health Research Summit

Workshops & Featured Speakers

Research Summit home page

Click the links below to explore workshop and presenter details


Monday Keynote Presentation

Prioritizing Possibilities for Child Flourishing: Our Greatest Public Health Opportunity

Monday, December 7 | 9:30 to 10:30 a.m. CST

Children can flourish amid adversity! While examining the current science and epidemiology of adverse childhood experiences (ACEs) and impacts on health and well-being, this keynote session will explore the prevalence and variations in child flourishing. Learn about existing policies, practices and resources to leverage a new integrated science of thriving to promote flourishing in the face of adversity and improve population mental health. New research regarding the possibilities for flourishing amid adversity and how to consider these issues in the context of existing practices and policy realities will be included.

Presented by Christina Bethell, PhD, Child & Adolescent Health Measurement Initiative Professor – Bloomberg School of Public Health at Johns Hopkins University


Tuesday Keynote Presentation

Resilience as Readiness: Ways to Support Provider and Family Well-Being

Monday, December 7 | 9:30 to 10:30 a.m. CST

The global pandemic and impact of racial injustices has resulted in increased stress for everyone.  A rapid transition to telehealth, remote learning, and working from home has disrupted routines and created additional stressors for families. Especially during times of distress, it is easy to not attend to one’s own wellbeing. Now, more than ever, it is essential to be ready to face to stress by calling upon resilience-building skills to support families and providers. Mechanisms of building resilience, the science of resilience, and practical tools to support provider and family well-being will be presented.

Presented by Lauren Marlotte, PsyD, Assistant Director of Training for the Nathanson Family Resilience Center – UCLA Semel Institute for Neuroscience and Human Behavior

Dr. Marlotte is the Assistant Director of Training for the Nathanson Family Resilience Center within the UCLA Semel Institute for Neuroscience and Human Behavior. She is also an attending supervisor at the UCLA Family Stress, Trauma, and Resilience clinic and the UCLA Psychology Clinic. Dr. Marlotte is a licensed clinical psychologist who received her doctorate from the University of La Verne, where she studied clinical and community psychology. Dr. Marlotte completed a pre-doctoral APA accredited clinical internship working primarily with underserved populations at an outpatient community mental health center and juvenile hall. Dr. Marlotte also completed a two year APA accredited post-doctoral fellowship at Children’s Hospital Los Angeles, where she specialized in working with adolescents, young adults, and their families. She earned her bachelor’s degrees from Occidental College in Cognitive Science and Kinesiology and her master’s degree from the University of La Verne in Clinical Psychology.


1. Partnering with Families to Identify Needs and Opportunities to Improve Policies, Service Quality and Child Well-Being

Monday, December 7 | Breakout Session 1 | 10:45 to 12:15 CST

This session will include a guided discussion addressing the following questions:

+ What progress have we/I made to address the challenges we face in our organization/community as it relates to ACEs and promoting healing and flourishing for children, youth and families?
+ What new opportunities do we/I have to further promote healing and flourishing as we address ACEs as part of the equation for children’s mental health? 
+ What mindsets, resources and structures must be maintained and how can these be enhanced? 
+ What new is needed?
+ What can we do now versus what changes in policy or new resources are needed?

Presented by keynote presenter Christina Bethell, PhD, Child & Adolescent Health Measurement Initiative Professor – Bloomberg School of Public Health at Johns Hopkins University


2. Protective Factors for Suicide in African American Adolescents and Young Adults

Monday, December 7 | Breakout Session 1 | 10:45 to 12:15 CST

This presentation will focus on suicide prevention strategies for adolescents and young adults from communities of color.  The presentation will present epidemiological data on the scope of the problem of suicidal thoughts and behaviors in youth from communities of color, describe risk and protective factors associated with suicide in these communities, discuss the research on treatment engagement for youth of color and explore using an upstream approach to suicide prevention for youth from these communities. Prevention in faith communities will be used as an example of an upstream approach, and information on the development of a suicide prevention in a predominantly Black church will be shared.

Sherry Davis Molock, PhD, MDiv, Department of Psychological Brain Sciences –– George Washington University


3. Child Suicide Risk, Assessment and Prevention: What We Know so Far

Monday, December 7 | Breakout Session 2 | 1:15 to 2:45 CST

In this panel discussion with researchers from the National Institutes of Mental Health, an overview will be provided of the epidemiology of suicide among children age 11 and younger. The panelists will summarize what research tells us about risk and protective factors, how to screen for and assess suicide risk, as well as evidence for intervention and prevention. Gaps in clinical and research knowledge and ethical considerations will be highlighted.

Lynsay Ayer, PhD – National Institute of Mental Health (NIMH) & RAND; Lisa Colpe, PhD – NIMH; Lisa Horowitz, PhD – NIMH; & Eve Reider, PhD – NIMH


4. Using Psychological Profiles to Identify Adolescent Girls at Risk for Self-Injury

Monday, December 7 | Breakout Session 2 | 1:15 to 2:45 CST

Self-injury is common in adolescents, especially among girls. To help identify adolescent girls who may need support prior to the first occurrence of self-injury, a better understanding of psychological vulnerabilities to this behavior was sought. During this session, the presenter will share recent findings from the Adolescent Development of Emotions and Personality Traits study, an ongoing longitudinal project tracking the health and wellbeing of girls from Long Island, New York. Results will be shared that point to two key psychological pathways to first onsets of adolescent self-harm in the community: disinhibition, an urgency to act and a difficulty regulating one’s behavior; and avoidance of upsetting memories or thoughts. The presenter will also discuss the role of parental personality and mental health in adolescent self-harm. Finally, the current research program has derived a personality profile with a good ability to identify adolescent girls who are at risk of initiating self-harm––and the potential clinical implications of this finding will be discussed.

Monika Waszczuk, PhD, Associate Professor of Psychology – Rosalind Franklin University of Medicine and Science


5. Using a Family and Resilience-Informed Lens in Reducing Adolescent Depression

Tuesday, December 8 | Breakout Session 3 | 10:45 to 12:15 CST

Adolescent depression impacts youth social, emotional and cognitive development; increases risk for suicide, substance abuse, and serious health risk behaviors; and is associated with decreased school performance. This presentation will describe the adaptation of the evidenced-based practice––Families OverComing Under Stress (FOCUS) for Depression––including the implementation and outcomes of a randomized controlled trial with low-income minority adolescents delivered through school-based clinics. 

Presented by Lauren Marlotte, PsyD, Assistant Director of Training for the Nathanson Family Resilience Center – UCLA Semel Institute for Neuroscience and Human Behavior


6. Adapting our Clinical Practice for Adolescent Mood Problems and Anxiety in Diverse Populations and Contexts Amid COVID-19

Tuesday, December 8 | Breakout Session 3 | 10:45 to 12:15 CST

In the context of the global pandemic, this workshop will present evidence from empirical studies and systematic reviews summarising the current state of the evidence pertaining to how disease containment measures could impact on mental health in adolescents. This will include a consideration of social isolation and loneliness. The talk will also highlight what we know so far about how adolescents across the world are experiencing the pandemic and how it is impacting on their mental health. Implications for clinical practice, including the evidence for remotely delivered interventions will be emphasised.

Dr. Maria Loades, Clinical Tutor for the Doctorate in Clinical Psychology – University of Bath


7. Brain Activity and Clinical Predictors of ADHD Medication Response

Tuesday, December 8 | Breakout Session 4 | 1:15 to 2:45

The combination of d-methylphenidate and guanfacine (an alpha adrenergic 2A agonist) has shown superior efficacy compared to monotherapy as a treatment for children with attention deficit hyperactivity disorder (ADHD). However, it is unclear what predicts and drives response to these treatments. During this session, the presenter will share recent work investigating whether pre-treatment clinical and brain activity profiles predict improvement in ADHD severity and whether the effects of each treatment on brain activity are related to clinical improvements. The findings may offer promising ways to aid personalized treatment decisions and treatment monitoring in child psychiatry.

Giorgia Michelini, PhD, Research Scholar – Division of Child & Adolescent Psychiatry in the Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA


8. Implementing Measurement-Based Care in a Large Multistate Behavioral Health System

Tuesday, December 8 | Breakout Session 4 | 1:15 to 2:45

The presenters of this session will discuss the application of measurement-based care, treatment standardization and self-report outcomes assessments and how those items have been implemented in a large behavioral health system. Implementing this evidence-based approach to care not only has improved patient satisfaction and outcomes, it has also reduced re-admissions and improved the quality and clinical effectiveness at Rogers Behavioral Health.

Bradley Riemann,  Chief Clinical Officer; Brian Kay, PhD, Vice President of Continuous Improvement; & Jessica Cook, MS, Director of Clinical Effectiveness – Rogers Behavioral Health